Trigger medications and patient-related risk factors for Parkinson disease psychosis requiring anti-psychotic drugs: a retrospective cohort study
Open Access
- 12 October 2013
- journal article
- Published by Springer Nature in BMC Neurology
- Vol. 13 (1) , 145
Abstract
Psychoses such as hallucinations are a frequent non-motor problem in patients with Parkinson disease (PD) and serious psychosis requires anti-psychotic medications that worsen Parkinsonism. Although psychosis could be associated with patient-related or biological factors such as cognition, age, and severity of PD, it can also be associated with medications.Keywords
This publication has 34 references indexed in Scilit:
- Psychosis in Parkinson's disease without dementia: Common and comorbid with other non‐motor symptomsMovement Disorders, 2012
- What predicts mortality in Parkinson disease?Neurology, 2010
- The changing face of Parkinson's disease‐associated psychosis: A cross‐sectional study based on the new NINDS‐NIMH criteriaMovement Disorders, 2010
- Four novel mutations in the GCH1 gene of Chinese patients with dopa‐responsive dystoniaMovement Disorders, 2010
- Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's diseaseBrain, 2009
- Nurse Staffing Level and Nosocomial Infections: Empirical Evaluation of the Case-Crossover and Case-Time-Control DesignsAmerican Journal of Epidemiology, 2007
- Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET studyMovement Disorders, 2006
- Double‐blind, placebo‐controlled, unforced titration parallel trial of quetiapine for dopaminergic‐induced hallucinations in Parkinson's diseaseMovement Disorders, 2005
- Antiparkinsonian medication is not a risk factor for the development of hallucinations in Parkinson?s diseaseJournal of Neural Transmission, 2004
- Hallucinations in Parkinson's disease: A follow‐up studyMovement Disorders, 2004